Your submission is now in Draft mode.

Once it's ready, please submit your draft for review by our team of Community Moderators. Thank you!

Submit Essay

Once you submit your essay, you can no longer edit it.


This content now needs to be approved by community moderators.


This essay was submitted and is waiting for review.

Phase III Trials on Cancer Vaccines in 2022


There is a lot of excitement about the use of mRNA technology to develop therapeutic cancer vaccines. The German firm BioNTech have four such vaccines undergoing Phase II trials at the moment.

Outside of the crisis-mode of pandemic vaccines, it usually takes years to get from Phase II to approval.

Will any of the ongoing BioNTech mRNA cancer vaccine trials proceed to Phase III trials in 2022?

If BioNTech declares during 2022 that any of its four ongoing Phase II trials into cancer vaccines (BNT111 for melanoma, BNT113 for head and neck cancer, BNT122 for melanoma and for colorectal cancer) will proceed to Phase III trials, this question will resolve positively. Otherwise it will resolve negatively.

Make a Prediction


Note: this question resolved before its original close time. All of your predictions came after the resolution, so you did not gain (or lose) any points for it.

Note: this question resolved before its original close time. You earned points up until the question resolution, but not afterwards.

Current points depend on your prediction, the community's prediction, and the result. Your total earned points are averaged over the lifetime of the question, so predict early to get as many points as possible! See the FAQ.